Cyclin-dependent kinase inhibitor 2A (p16) distinguishes well-differentiated liposarcoma from lipoma.

Gonzalez RS, McClain CM, Chamberlain BK, Coffin CM, Cates JM
Histopathology. 2013 62 (7): 1109-11

PMID: 23600700 · DOI:10.1111/his.12112

MeSH Terms (10)

Biomarkers, Tumor Cyclin-Dependent Kinase Inhibitor p16 Diagnosis, Differential Female Humans Lipoma Liposarcoma Male Middle Aged Soft Tissue Neoplasms

Connections (2)

This publication is referenced by other Labnodes entities:

Links